1. From the Division of Diagnostic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Pathology, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; and the Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI